Fluorine-18-fluorocyclopropylhexadecanoic acid

Drug Profile

Fluorine-18-fluorocyclopropylhexadecanoic acid

Alternative Names: 18F-FCPHA; 18F-fluorocyclopropylhexadecanoic acid; Cardiac PET imaging agent - FluoroPharma; CardioPET; FCPHA; Fluorocyclopropylhexadecanoic acid-F-18; trans-9-18F-Fluoro-3,4-methylenehepadecanoic acid

Latest Information Update: 04 Nov 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Harvard Medical School; Massachusetts General Hospital
  • Developer FluoroPharma
  • Class Fatty acids; Imaging agents; Radiopharmaceutical diagnostics
  • Mechanism of Action Positron-emission tomography enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Coronary artery disease

Most Recent Events

  • 04 Nov 2017 No recent reports of development identified for phase-I development in Coronary artery disease(Diagnosis) in USA (IV, Injection)
  • 31 Mar 2017 FluoroPharma has patent protection for the composition and method of use of 18-F FCPHA and 18-F FTPP technologies
  • 06 Jun 2016 Fluorine-18-fluorocyclopropylhexadecanoic acid licensed to Hainan Sinotau Pharmaceutical in China and Canada
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top